Nishioka, Yasuhiko
Araya, Jun
Tanaka, Yoshiya
Kumanogoh, Atsushi
Funding for this research was provided by:
Nippon Boehringer Ingelheim
Article History
Received: 14 May 2024
Accepted: 24 June 2024
First Online: 19 July 2024
Declarations
:
: Not applicable.
: The authors did not receive payment related to the development of this manuscript. YN has received speaking fees and/or honoraria from Asahi Kasei Pharma, Amgen, AstraZeneca, Boehringer Ingelheim, Chugai, Eisai, Kyorin, MSD, Pfizer, Pharma Foods, Sanofi, and Takeda; and received research grants from Asahi Kasei Pharma, Boehringer Ingelheim, Chugai, Kyorin, Nippon Kayaku, Otsuka, Taiho, and Teijin Pharma. JA has received speaking fees and/or honoraria from AstraZeneca, Boehringer Ingelheim, GSK, Sanofi, Kowa, and Kyorin; and received research grants from Kowa, Kyorin, Taiho, and Boehringer Ingelheim. YT has received speaking fees and/or honoraria from Eli Lilly, AstraZeneca, AbbVie, Gilead, Chugai, Boehringer Ingelheim, GSK, Eisai, Taisho, Bristol Myers Squibb, Pfizer, and Taiho; and received research grants from Mitsubishi Tanabe Pharma, Eisai, Chugai, and Taisho. AK is an Editor of <i>Inflammation and Regeneration</i> and has received speaking fees and/or honoraria from Eli Lilly, AstraZeneca, AbbVie, Gilead, Chugai, Boehringer Ingelheim, GSK, Eisai, Taisho, Bristol Myers Squibb, Pfizer, and Taiho; and received research grants from Eisai, Chugai, and Otsuka.